Announce Date | 05/01/2025 |
EPS Normalized Actual | $1.6 (Beat by $0.12) |
EPS GAAP Actual | $1.6 (Beat by $0.12) |
Revenue Actual | $0.624861B |
Revenue Surprise | Beat by $624.861M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 8.55 | 12.47 | 8.47901 | 8.58651 | 1 |
Dec 2026 | 7.06678 | 15.08 | 7.01 | 7.12355 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.29 | 1.29 | 0.624861B | 14.27% | 624.86M |
FQ4 2024 (Dec 2024) | 1.45 | 1.45 | 0.666042B | 5.89% | 666.04M |
FQ3 2024 (Sep 2024) | 1.32 | 1.32 | 0.654926B | -5.7% | 654.93M |
FQ2 2024 (Jun 2024) | 1.21 | 1.21 | 0.604336B | 100% | 604.34M |
FQ1 2024 (Mar 2024) | 0.91 | 0.91 | 0.535675B | -19.81% | 535.68M |
FQ4 2023 (Oct 2023) | 1.72 | 1.72 | 0.626807B | -5.15% | 626.81M |
FQ3 2023 (Jul 2023) | 1.62 | 1.62 | 0.692245B | 100% | 692.25M |
FQ1 2023 (Mar 2023) | 1.48 | 1.48 | 0.641789B | 100% | 641.79M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 2.3121 | -- | 2.30642 | 2.3242 | 1 |
FQ2 2027 (Jun 2027) | 2.18065 | -- | 2.17529 | 2.19206 | 1 |
FQ1 2027 (Mar 2027) | 1.81868 | -- | 1.81421 | 1.8282 | 1 |
FQ4 2026 (Dec 2026) | 2.00929 | -- | 1.98865 | 2.03884 | 1 |
FQ3 2026 (Sep 2026) | 2.06256 | -- | 2.04138 | 2.09289 | 1 |
FQ2 2026 (Jun 2026) | 2.07602 | -- | 2.0547 | 2.10655 | 1 |
FQ1 2026 (Mar 2026) | 1.75472 | 26.48 | 1.7367 | 1.78053 | 1 |
FQ4 2025 (Dec 2025) | 1.99902 | 27.46 | 1.97849 | 2.02842 | 1 |
FQ3 2025 (Sep 2025) | 1.99536 | 33.85 | 1.97487 | 2.02471 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.75B | -- | 0.75B | 0.75B | 2 |
FQ2 2027 (Jun 2027) | 0.74B | -- | 0.74B | 0.74B | 2 |
FQ1 2027 (Mar 2027) | 0.68B | -- | 0.67B | 0.68B | 2 |
FQ4 2026 (Dec 2026) | 0.72B | -- | 0.71B | 0.73B | 2 |
FQ3 2026 (Sep 2026) | 0.73B | -- | 0.73B | 0.74B | 2 |
FQ2 2026 (Jun 2026) | 0.74B | -- | 0.74B | 0.75B | 2 |
FQ1 2026 (Mar 2026) | 0.67B | 6.2 | 0.66B | 0.67B | 2 |
FQ4 2025 (Dec 2025) | 0.7B | 4.58 | 0.69B | 0.71B | 1 |
FQ3 2025 (Sep 2025) | 0.7B | 6.55 | 0.7B | 0.71B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.29 | 1.29 | 100% | |
FQ4 2024 (Dec 2024) | 1.45 | 1.45 | 100% | |
FQ3 2024 (Sep 2024) | 1.32 | 1.32 | 100% | |
FQ2 2024 (Jun 2024) | 1.21 | 1.21 | 100% | |
FQ1 2024 (Mar 2024) | 0.91 | 0.91 | 100% | |
FQ4 2023 (Oct 2023) | 1.72 | 1.72 | 100% | |
FQ3 2023 (Jul 2023) | 1.62 | 1.62 | 100% | |
FQ1 2023 (Mar 2023) | 1.48 | 1.48 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $0.62B | $624.86M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.67B | $666.04M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.65B | $654.93M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.6B | $604.34M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.54B | $535.68M | 100% |
FQ4 2023 (Oct 2023) | $0B | $0.63B | $626.81M | 100% |
FQ3 2023 (Jul 2023) | $0B | $0.69B | $692.25M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0.64B | $641.79M | 100% |